Curriculum for endoscopic submucosal dissection training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 31 8 2019
medline: 25 6 2020
entrez: 31 8 2019
Statut: ppublish

Résumé

There is a need for well-organized comprehensive strategies to achieve good training in ESD. In this context, the European Society of Gastrointestinal Endoscopy (ESGE) have developed a European core curriculum for ESD practice across Europe with the aim of high quality ESD training.Advanced endoscopy diagnostic practice is advised before initiating ESD training. Proficiency in endoscopic mucosal resection (EMR) and adverse event management is recommended before starting ESD trainingESGE discourages the starting of initial ESD training in humans. Practice on animal and/or ex vivo models is useful to gain the basic ESD skills. ESGE recommends performing at least 20 ESD procedures in these models before human practice, with the goal of at least eight en bloc complete resections in the last 10 training cases, with no perforation. ESGE recommends observation of experts performing ESD in tertiary referral centers. Performance of ESD in humans should start on carefully selected lesions, ideally small ( < 30 mm), located in the antrum or in the rectum for the first 20 procedures. Beginning human practice in the colon is not recommended. ESGE recommends that at least the first 10 human ESD procedures should be done under the supervision of an ESD-proficient endoscopist.Endoscopists performing ESD should be able to correctly estimate the probability of performing a curative resection based on the characteristics of the lesion and should know the benefit/risk relationship of ESD when compared with other therapeutic alternatives. Endoscopists performing ESD should know how to interpret the histopathology findings of the ESD specimen, namely the criteria for low risk resection ("curative"), local risk resection, and high risk resection ("non-curative"), as well as their implications. ESD should be performed only in a setting where early and delayed complications can be managed adequately, namely with the possibility of admitting patients to a ward, and access to appropriate emergency surgical teams for the organ being treated with ESD.

Identifiants

pubmed: 31470448
doi: 10.1055/a-0996-0912
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

980-992

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

F. Berr has received financial support from Ethical MedTech (Olympus, Fujifilm, ERBE, and others) to organize medical education courses and live endoscopy events (2009 – 2019), and speaker’s fees from Olympus (2015 – 2018). R. Bisschops has received research support from Cook and Medtronic, and financial support for symposium organization from Cook, Boston Scientific, Olympus, and Erbe (2009 – 2019), and speaker's fees from Boston Scientific and Medtronic (2009 – 2019). E. Dekker has received speaker’s fees from Olympus, Roche, and GI Supply, has provided consultancy to FujiFilm, Olympus, Tillots, GI Supply, and CPP-FAP, and is a member of the supervisory board of eNose; she receives a research grant from FujiFilm (2017 to present). P. Deprez has provided consultancy to Olympus, Erbe, and Boston Scientific (2015 – 2019). M. Dinis-Ribeiro is co-editor in-chief of

Auteurs

Pedro Pimentel-Nunes (P)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for research in health technologies and information systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.
Surgery and Physiology Department, Faculty of Medicine of the University of Porto, Porto, Portugal.

Mathieu Pioche (M)

Gastroenterology division, Edouard Herriot Hospital, Lyon, France.

Eduardo Albéniz (E)

Gastroenterology Department, Endoscopy Unit, Complejo Hospitalario de Navarra, Pamplona, Spain.
Navarrabiomed, Universidad Pública de Navarra, IdiSNa, Pamplona, Spain.

Frieder Berr (F)

Department of Medicine I, Paracelsus Medical University, Salzburg, Austria.

Pierre Deprez (P)

Department of Hepato-Gastroenterology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

A Ebigbo (A)

Department of Gastroenterology, Universitätsklinikum Augsburg, Germany.

Pieter Dewint (P)

Department of Gastroenterology and Hepatology, AZ Maria-Middelares, Ghent, Belgium.
Department of Gastroenterology and Hepatology, UZA, Antwerp, Belgium.

Amyn Haji (A)

King's Institute of Therapeutic Endoscopy, King's College Hospital, Denmark Hill, London, UK.

Alba Panarese (A)

National Research Institute Specialized in Gastroenterology "S. de Bellis" - IRCCS, Castellana Grotte (BA), Italy.

Bas L A M Weusten (BLAM)

Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, The Netherlands.
Department of Gastroenterology and Hepatology, St Antonius Hospital Nieuwegein, The Netherlands.

Evelien Dekker (E)

Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.

James E East (JE)

Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre, Oxford, UK.

David S Sanders (DS)

Academic Unit of Gastroenterology, Royal Hallamshire Hospital, Sheffield, UK.

Gavin Johnson (G)

University College London Hospitals, London, UK.

Marianna Arvanitakis (M)

Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium.

Thierry Ponchon (T)

Gastroenterology division, Edouard Herriot Hospital, Lyon, France.

Mário Dinis-Ribeiro (M)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for research in health technologies and information systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.

Raf Bisschops (R)

Department of Gastroenterology and Hepatology, University Hospitals Leuven, and TARGID, KU Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH